| Primary |
| Influenza |
45.2% |
| Drug Use For Unknown Indication |
22.7% |
| Product Used For Unknown Indication |
8.7% |
| H1n1 Influenza |
8.1% |
| Antiviral Prophylaxis |
3.6% |
| Prophylaxis |
1.9% |
| Pyrexia |
1.9% |
| Hypertension |
1.3% |
| Asthma |
0.9% |
| Cough |
0.9% |
| Influenza Immunisation |
0.8% |
| Influenza Like Illness |
0.8% |
| Pneumonia |
0.5% |
| Diabetes Mellitus |
0.5% |
| Epilepsy |
0.5% |
| Insomnia |
0.4% |
| Parkinson's Disease |
0.4% |
| Bronchitis |
0.4% |
| Convulsion |
0.3% |
| Pain |
0.3% |
|
| Abnormal Behaviour |
14.8% |
| Pregnancy |
10.7% |
| No Adverse Event |
10.2% |
| Vomiting |
8.6% |
| Drug Exposure During Pregnancy |
7.8% |
| Normal Newborn |
6.6% |
| Overdose |
6.2% |
| Hallucination |
5.8% |
| Convulsion |
4.0% |
| Pneumonia |
3.7% |
| Death |
3.7% |
| Delirium |
3.6% |
| Loss Of Consciousness |
2.2% |
| Accidental Overdose |
2.1% |
| Depressed Level Of Consciousness |
1.9% |
| Hypothermia |
1.7% |
| Drug Ineffective |
1.7% |
| Influenza |
1.7% |
| Pyrexia |
1.6% |
| Rash |
1.5% |
|
| Secondary |
| Influenza |
32.8% |
| Drug Use For Unknown Indication |
14.8% |
| Product Used For Unknown Indication |
14.6% |
| Pyrexia |
5.1% |
| Hypertension |
4.6% |
| H1n1 Influenza |
3.9% |
| Parkinson's Disease |
3.0% |
| Pneumonia |
2.7% |
| Maternal Exposure Timing Unspecified |
2.5% |
| Cough |
2.3% |
| Nasopharyngitis |
1.7% |
| Infection |
1.5% |
| Bronchitis |
1.5% |
| Foetal Exposure During Pregnancy |
1.5% |
| Prophylaxis |
1.4% |
| Insomnia |
1.4% |
| Upper Respiratory Tract Inflammation |
1.4% |
| Gastritis |
1.2% |
| Back Pain |
1.2% |
| Lower Respiratory Tract Infection |
1.1% |
|
| Abnormal Behaviour |
18.9% |
| Overdose |
12.4% |
| Vomiting |
8.4% |
| No Adverse Event |
7.2% |
| Delirium |
5.1% |
| Hallucination |
5.0% |
| Rhabdomyolysis |
4.8% |
| Loss Of Consciousness |
4.0% |
| Pneumonia |
3.8% |
| Somnambulism |
3.8% |
| Liver Disorder |
3.4% |
| Restlessness |
3.4% |
| Suicidal Ideation |
2.9% |
| Enterocolitis Haemorrhagic |
2.7% |
| Fall |
2.7% |
| Urine Output Increased |
2.7% |
| Hypothermia |
2.3% |
| Pyrexia |
2.3% |
| Sepsis |
2.3% |
| White Blood Cell Count Decreased |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.4% |
| Drug Use For Unknown Indication |
14.3% |
| Influenza |
10.2% |
| Prophylaxis |
6.9% |
| Multiple Myeloma |
6.0% |
| Hypertension |
5.1% |
| Contraception |
4.8% |
| Pain |
4.7% |
| Pneumonia |
4.0% |
| Sepsis |
3.2% |
| Rheumatoid Arthritis |
3.1% |
| Depression |
2.9% |
| Anxiety |
2.4% |
| Schizophrenia |
2.1% |
| Cough |
1.9% |
| Osteoporosis |
1.9% |
| H1n1 Influenza |
1.8% |
| Nausea |
1.8% |
| Pyrexia |
1.8% |
| Acne |
1.8% |
|
| Weight Decreased |
10.6% |
| Vomiting |
7.3% |
| Pulmonary Embolism |
6.9% |
| Pyrexia |
6.5% |
| Pneumonia |
6.1% |
| White Blood Cell Count Increased |
6.1% |
| Death |
5.7% |
| Viral Infection |
5.3% |
| Deep Vein Thrombosis |
4.9% |
| Pain |
4.9% |
| Thrombocytopenia |
4.9% |
| Influenza |
4.5% |
| Nausea |
3.7% |
| Paraesthesia |
3.7% |
| Rash |
3.3% |
| Respiratory Failure |
3.3% |
| Thrombosis |
3.3% |
| Wheezing |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Stevens-johnson Syndrome |
2.8% |
|
| Interacting |
| Influenza |
21.9% |
| Atrial Fibrillation |
18.8% |
| Product Used For Unknown Indication |
15.6% |
| Pulmonary Embolism |
12.5% |
| Hepatitis C |
9.4% |
| Deep Vein Thrombosis |
6.3% |
| Lower Respiratory Tract Infection |
6.3% |
| Acute Tonsillitis |
3.1% |
| Cardiac Valve Disease |
3.1% |
| H1n1 Influenza |
3.1% |
|
| International Normalised Ratio Increased |
40.0% |
| Drug Interaction |
28.0% |
| H1n1 Influenza |
8.0% |
| Cough |
4.0% |
| Haemoptysis |
4.0% |
| Hepatitis C |
4.0% |
| Pyrexia |
4.0% |
| Torsade De Pointes |
4.0% |
| Vomiting |
4.0% |
|
